Pharmaceutical Preparations

	Potential new drug identified as a result of the research study.

Pharmaceutical preparations are defined by the National Library of Medicine as drugs intended for human or veterinary use, presented in their finished dosage form. Pharmaceutical preparations can be considered as biological material applications when they reflect an approach based on understanding of details at the molecular level.

Some research studies result in the development of a new drug. According to the FDA, each new drug requires an average of 10-15 years of testing and review, with most drugs not moving on to the clinical trial phase. If a drug developed during a pre-clinical (bench) study shows promise, the next step is a series of clinical trial studies, starting with a Phase I clinical trial to determine if the drug is safe for humans.

Assessment

Documentation by research study investigators of new drug development is recommended for tracking of research output.

	Search using the keywords, title or the name of the author/research study.

A resource that may be helpful is the RePORT Expenditures and Results (RePORTER) database. RePORTER is a database on federally funded biomedical research projects conducted at universities, hospitals, and other research institutions supported by the Department of Health and Human Services (DHHS). RePORTER provides additional query fields, hit lists that can be sorted and downloaded to Excel, NIH funding for each project (expenditures), and the publications and patents that have acknowledged support from each project (results). RePORTER also provides links to PubMed Central, PubMed, and the U.S. Patent & Trademark Office Patent Full Text and Image Database for more information on research results. Some bench studies for pharmaceutical preparations funded by DHHS may be noted in the RePORTER database.

Back to Top

Last updated: July 31, 2009